Stock Ticker

  • Loading stock data...

Johnson & Johnson (NYSE:JNJ) Expects To Deliver Over 1 Billion Doses Of Vaccine For COVID-19 And Commence Clinical Trials By September 2020

Johnson & Johnson (NYSE:JNJ) has decided to produce over 1 billion doses of vaccine for COVID-19 by teaming up with the Biomedical Advanced Research and Development Authority (BARDA) in the US. It is an extension of the existing accord between the Janssen Pharmaceutical Companies division of Johnson & Johnson and BARDA. The first batch of affordable […]

Target Corporation (NYSE:TGT) and Kroger Co (NYSE:KR) Ramp Up Fight Against COVID-19 in Stores

Retail giants Target Corporation (NYSE:TGT) and  Kroger Co (NYSE:KR) are doing everything in their power to maintain operations, even as the Corona pandemic continues to trigger massive shutdown across the U.S. The two retailers have resorted to ingenious ways to try and curb the spread of the coronavirus within their brick and mortar stores. COVID-19 […]

Investing in the Age of Coronavirus (INO, APT, CODX, SGMD, IBIO, AYTU)

The market is crashing almost every day right now. If you own the SPY, or a basket of large-cap leadership stocks that have defined this bull market for years, you’re getting destroyed over the past three weeks. But there is an answer. A small group of stocks has been rallying precisely because of the impact […]

Gilead Sciences Inc. (NASDAQ:GILD) Commences Two Phase 3 Clinical Trials of Remdesivir For COVID-19 Treatment

Gilead Sciences Inc. (NASDAQ:GILD) has announced that it is expanding clinical trials for its antiviral drug remdesivir as a potential treatment of COVID-19 in countries outside China. Gilead to expand clinical trials of remdsivir to other countries outside china The company now expects to begin two new remdesivir clinical trials in March across Asia and […]

Walgreens Boots Alliance (NASDAQ: WBA) To Pay $7.5 Million To Settle Lawsuit Regarding Unlicensed Pharmacist

Walgreens Boots Alliance (NASDAQ:WBA) has agreed to settle a consumer protection lawsuit by paying $7.5 million after Alameda County District Attorney claimed that one of Walgreens ’pharmacists had worked in the Bay Area over a decade without a license. Walgreens pharmacist handled 745,000 prescriptions without a license. Prosecutors indicated that Kim Thien Le had handled […]

Myriad Genetics (NASDAQ:MYGN) Shares Stop Bleeding on Positive Study of Prenatal Genetics Test

It’s certainly been a white-knuckle ride in 2019 for shareholders of the molecular diagnostics and precision medicines company Myriad Genetics (NASDAQ: MYGN), with shares doubling and getting halved over a few weeks this summer. A slow climb starting in June from $22 culminated with a 55% explosion on August 1-2 to $48 thanks to news […]

Innovators in the Booming Pharmacy Services Space (WBA, RXMD, CERN, MDRX, CVS)

The market is ripping higher. But one of the most important leadership areas isn’t what most retail investors generally think about when they think of big capital gains growth. The pharmacy services space is the focus here. It’s a staple. Demand is inelastic within the context of the market cycle – these stocks generally won’t […]

Sanofi SA (NASDAQ:SNY) Would Focus On Cancer Treatments For Rapid Growth: Sanofi In Advanced Stage To Divest Seprafilm

Sanofi SA (NASDAQ:SNY) is in advanced talks to divest Seprafilm to Baxter International Inc (NYSE:BAX). Seprafilm is valued at up to $400 million. It is used to eliminate scars resulting from pelvic and abdominal surgeries. Sanofi intends to focus on cancer treatments to achieve rapid growth. Products to reduce complications Baxter is engaged in the […]

CVS Health Corp (NYSE:CVS) Suspends Sale of Zantac Over Cancer Concerns

CVS Health Corp (NYSE:CVS) has announced that will no longer sell heartburn drug Zantac which the FDA is investigating for links to cancer. The company announced on Saturday that it was suspending over-the-counter sales of the drug as a caution. Zantac could have cancer casing carcinogen The move comes after concerns from several countries about […]

Amgen Inc. (NASDAQ:AMGN) Announces The Purchase of Immunology Drug Otezla from Celgene Corporation (NASDAQ:CELG)

Amgen Inc. (NASDAQ:AMGN) has announced the purchase of Celgene Corporation’s (NASDAQ:CELG) leading immunology drug Otezla for around $13.4 billion. Otezla purchase deal to be finalized at the end of the year The company has indicated that the deal will be closed at the end of the year. Following the announcement, Amgen’s stock gained 2.85% to […]

Walgreens Boots Alliance Inc (NASDAQ:WBA) Announces Plans To Shut Down 200 Stores In The U.S Due To Cost Cutting

Walgreens Boots Alliance Inc (NASDAQ:WBA) revealed in a regulatory filing on Tuesday that it plans to shut down 200 of its outlets in the U.S as part of its cost-cutting efforts. The company filed a regulatory filing on Tuesday, through which it revealed the plan to close down more than 200 stores in the U.S. […]

Medexus Pharma Revenue and Profits Surge on Acquisitions

Following Monday’s closing bell, Canadian specialty pharma company Medexus Pharmaceuticals (TSX-V:MDP)(OTCQB:PDDPF) released its results from operations for the quarter and fiscal year ended March 31, 2019 showing a dramatic improvement in the top and bottom lines compared to a year earlier.  The books were catalyzed by the company formerly known as Pediapharm completing mergers with […]

Novartis AG (NYSE:NVS) Announces New Clinical Study Updates at the ASCO 2019 Meeting

Novartis AG (NYSE:NVS) posted new clinical study updates in NSCLC at the recently held ASCO 2019 Annual Meeting. This comprised primary efficacy data from the GEOMETRY mono-1 Phase 2 clinical study. It showed that INC280 comes as a potential treatment alternative for subjects with metastatic or locally advanced NSCLC that has MET exon-14 skipping mutation. […]

Merck & Co., Inc. (NYSE:MRK) Gets FDA Nod For ZERBAXA

Merck & Co., Inc. (NYSE:MRK) reported that the U.S. Food and Drug Administration has approved expanded use of its antibiotic to cure hospital-acquired pneumonia in people 18 years and older. This nod comes on the back of the treatment’s late-stage study data, which indicated that Zerbaxa was effective as an antibacterial drug. Zerbaxa was included […]

Sign Up To Get Our Latest Stocks Alerts